A paucity of information currently exists on plasma bile acid (BA) profiles in patients with and
without type 2 diabetes mellitus (T2DM). We assayed 14 plasma BA species in 224 patients …

Background Liver transplantation is the definitive treatment for end-stage liver failure, but the
scarcity of donor organs remains a significant challenge. Leveraging organs from extended …

Studies investigating the potential role of circulating bile acids (BAs) as diagnostic
biomarkers for cholangiocarcinoma (CCA) are sparse and existing data do not adjust for …

Surgical removal is the primary treatment for liver cancer, but frequent recurrence caused by
residual malignant tissue remains an important challenge, as recurrence leads to high …

Atherosclerosis (AS) is a metabolic disorder and the pre-stage of several cardiovascular
diseases, including myocardial infarction, stroke, and angina pectoris. Early detection of AS …

Bile acids (BAs) are involved in the development of necrotizing enterocolitis (NEC), which
mainly occurs in preterm infants. We aim to identify the change of BAs in preterm infants and …

Bile acid (BA) play an important role in nutrient absorption and are key regulators of
antioxidant and immune response homeostasis. The purpose of this study was to evaluate …

Bile acids (BAs) assessments are garnering increasing interest for their potential
involvement in development and progression of cholangiocarcinoma (CCA). Since machine …

Imaging tests, tumor marker (TM) screening, and biochemical tests provide a definitive
diagnosis of hepatocellular carcinoma (HCC). However, some patients with HCC may …

Background Although a considerable number of research was published about the analysis
of bile acids in the past decades, their quantitative determination from biological matrices is …